ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 437 filers reported holding ENCOMPASS HEALTH CORP in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $658 | -3.9% | 9,791 | -3.3% | 0.00% | 0.0% |
| Q2 2023 | $685 | +34.8% | 10,122 | +7.7% | 0.00% | 0.0% |
| Q1 2023 | $508 | +81.4% | 9,396 | +100.3% | 0.00% | 0.0% |
| Q4 2022 | $280 | -99.9% | 4,692 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $204,000 | -31.1% | 4,518 | -14.5% | 0.00% | 0.0% |
| Q2 2022 | $296,000 | -19.3% | 5,285 | +2.4% | 0.00% | 0.0% |
| Q1 2022 | $367,000 | +28.3% | 5,161 | +17.7% | 0.00% | 0.0% |
| Q4 2021 | $286,000 | -1.4% | 4,385 | +13.3% | 0.00% | 0.0% |
| Q3 2021 | $290,000 | -7.3% | 3,870 | -3.7% | 0.00% | 0.0% |
| Q2 2021 | $313,000 | -12.1% | 4,017 | -7.7% | 0.00% | 0.0% |
| Q1 2021 | $356,000 | -3.0% | 4,350 | -2.2% | 0.00% | 0.0% |
| Q4 2020 | $367,000 | +29.7% | 4,449 | +2.0% | 0.00% | 0.0% |
| Q3 2020 | $283,000 | +18.9% | 4,361 | +13.3% | 0.00% | 0.0% |
| Q2 2020 | $238,000 | +11.7% | 3,849 | +15.5% | 0.00% | 0.0% |
| Q1 2020 | $213,000 | -16.5% | 3,333 | -9.7% | 0.00% | 0.0% |
| Q4 2019 | $255,000 | – | 3,690 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 396,670 | $27,477,000 | 7.28% |
| Endurant Capital Management LP | 163,092 | $11,297,000 | 3.56% |
| REINHART PARTNERS, LLC. | 656,158 | $45,452,000 | 3.34% |
| RK Capital | 117,590 | $8,145,000 | 3.05% |
| HIGH POINTE CAPITAL MANAGEMENT LLC | 27,150 | $1,881,000 | 2.23% |
| Wolf Group Capital Advisors | 47,461 | $3,288,000 | 2.16% |
| Copeland Capital Management, LLC | 631,346 | $43,734,000 | 1.92% |
| Advantage Alpha Capital Partners LP | 100,722 | $6,977,000 | 1.88% |
| Rock Springs Capital Management LP | 815,000 | $56,455,000 | 1.78% |
| Kalos Management, Inc. | 61,180 | $4,237,000 | 1.54% |